menu
    • menu

    Company profile for Nostrum Laboratories

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nostrum develop and market competitively priced quality products, that offer maximum benefits to patients; while we combine enduring pursuits of continuous learning, technology enhancement, business efficiency improvement, and enriching our associates’ lives"

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nostrum LaboratoriesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Nostrum Laboratories, Inc.1800 N Topping AveKansas City, MO 64120.
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nostrumlabs.com/Default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of August 6, 2025
    Enforcement Report - Week of August 6, 2025

    06 Aug 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-6-2025-14145.pdf

    FDA
    06 Aug 2025
    Share Share
    Nostrum Lab Issues Voluntary Nationwide Recall of sucralfate
    Nostrum Lab Issues Voluntary Nationwide Recall of sucralfate

    14 Jul 2025

    // FDA

    http://fda.gov/safety/recalls-market-withdrawals-safety-alerts/nostrum-laboratories-inc-issues-voluntary-nationwide-recall-sucralfate-tablets-usp-1-gram-within

    FDA
    14 Jul 2025
    Share Share
    Strides acquires identified ANDAs from Nostrum Laboratories
    Strides acquires identified ANDAs from Nostrum Laboratories

    29 Apr 2025

    // PRESS RELEASE

    https://www.strides.com/Upload/PDF/StridesSEIntimation_29_Apr_2025.pdf

    PRESS RELEASE
    29 Apr 2025
    Share Share
    Nostrum Labs Generic Doxycycline Hyclate Receives Approval In US
    Nostrum Labs Generic Doxycycline Hyclate Receives Approval In US

    15 Apr 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209560

    FDA
    15 Apr 2024
    Share Share
    Nostrum agrees to $50M with DOJ over allegations of underpaying Medicaid
    Nostrum agrees to $50M with DOJ over allegations of underpaying Medicaid

    31 Oct 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/nostrum-agrees-to-50m-settlement-with-doj-over-allegations-of-underpaying-medicaid/

    Katherine Lewin ENDPTS
    31 Oct 2023
    Share Share
    Nostrum's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.
    Nostrum's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.

    04 Apr 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200430

    FDA
    04 Apr 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search